CERO · Forms 3, 4, 5
Insider trades at CERO THERAPEUTICS HOLDINGS, INC.
No open-market insider buys or sells at CERO THERAPEUTICS HOLDINGS, INC. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for CERO THERAPEUTICS HOLDINGS, INC. (CERO) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for CERO THERAPEUTICS HOLDINGS, INC. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Eric Francois | Director | Options or other derivatives | Form 4 | ||||
| Eric Francois | Director | Became an insider (Form 3) | Form 3 | ||||
| Lindsey Rolfe | Director | Options or other derivatives | Form 4 | ||||
| Kathleen Laporte | Director | Options or other derivatives | Form 4 | ||||
| Kristen Pierce | Chief Development Officer | Options or other derivatives | Form 4 | ||||
| Shami Patel | Director | Options or other derivatives | Form 4 | ||||
| Brian G Atwood | Director | Options or other derivatives | Form 4 | ||||
| Christopher B Ehrlich | Chairman and CEO | Options or other derivatives | Form 4 | ||||
| Michael Byrnes | Director | Options or other derivatives | Form 4 | ||||
| Andrew Albert Kucharchuk | Chief Financial Officer | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.